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Abstract
Background: The antioxidant and anti-inflammatory properties of tarragon make it known as an antidiabetic plant. Diabetes mel-
litus, an endocrine, metabolic disease, is a leading global health emergency and associated with serious complications.
Objectives: This study aimed to assess the effects of tarragon powder supplementation on glucose metabolism, lipid profile, and
antioxidant status in the diabetic population.
Methods: Patient screening and selection for this clinical trial lasted one month. Tarragon supplement consumption by patients
lasted 2 months (8 weeks); meanwhile, they were followed up. Sixty male and female patients with type 2 diabetes were randomly
assigned to the tarragon receiver group (n = 30) and placebo receiver group (n = 30). The intervention group received a tarragon
capsule (500 mg) 3 times a day, and the control group received placebo capsules. Fasting blood glucose (FBG), two-hour postprandial
glucose (2-hpp), glycated hemoglobin (HbA1c), insulin, lipid, and antioxidant profile were evaluated at the start and the end of the
research.
Results: In the tarragon receiver group, FBG, 2-hpp, HbA1c%, insulin resistance, lipid, and antioxidant profile significantly improved,
compared to the placebo group, after adjuvant therapy with tarragon (P < 0.05).
Conclusions: Supplementation with tarragon powder in type II patients with diabetes for 2 months exerts a beneficial effect on
improving the glycemic profile, lipid profile, and antioxidant status.
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1. Background
One of the main public health problems is diabetes
mellitus (DM), which affects people at an escalating rate
worldwide (1). According to statistics, there is a future es-
timation of 629 million patients with diabetes by 2045 (2).
Hyperglycemia is the main characteristic of diabetes mel-
litus caused by defects in insulin function. There are two
main types of DM: type 1 diabetes (T1D) and type 2 diabetes
(T2D). Type 2 diabetes is a chronic metabolic disorder clas-
sically identified by hyperglycemia and insulin resistance
(3). The overall damaging impact of hyperglycemia are cat-
egorized as macrovascular issues (coronary artery disease,
peripheral artery disease, and stroke) and microvascular
issues (diabetic nephropathy, neuropathy, and retinopa-
thy) (4).
Autoimmune impairment of pancreas β-cells follow-
ing insulin deficiency leads to insulin resistance (5). One
of the factors in the elevation of reactive oxygen species
(ROS) is hyperglycemia that causes glycation of scavenging
enzymes and reduction in anti-oxidative mechanisms. It
is suggested that reduction of ROS production might have
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